Dolby Laboratories, Inc. (DLB) Stock Price & Analysis
Dolby Laboratories, Inc. (DLB) closed at USD 60.83 on Thursday, October 15, 2026, up 3.38% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 58.84; the Oct 15, 2026 session ranged USD 59.17–60.88 on volume of 479,664 shares. Market capitalization is $5.70B, with a 52-week range of USD 48.26–69.95 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:19 UTC.
Also available as compact Markdown for AI agents: nexqual.com/DLB.md
Key facts (DLB)
- Analysts: Buy (mean 2.00 on a 1–5 scale) (4 analysts), mean target USD 79 (range 62–90).
- Total return with dividends: 1Y -8.7% vs S&P 500 +18.1%; 5Y -26.5% vs S&P 500 +85.1%.
- Next earnings: 2026-11-17, EPS estimate USD 1.2, revenue estimate $373M.
Analysts (DLB)
Consensus Buy (mean 2.00 on a 1–5 scale), 4 analysts; mean target USD 79 (low 62, high 90).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-28 | Rosenblatt | Maintained | Buy | $85 |
| 2026-07-31 | Rosenblatt | Maintained | Buy | $85 |
Total return (dividends reinvested) (DLB)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -8.7% | -26.5% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -8.7% | -6.0% |
| Volatility (annualized) | 29.4% | 26.5% |
| Max drawdown | -29.4% (Feb 2026→Jul 2026) | -44.6% (Dec 2021→Jul 2026) |
Key Statistics (as of October 16, 2026 at 05:19 UTC)
| Price | USD 60.83 |
|---|---|
| Change | ▲ 3.38% (up) |
| Previous Close | USD 58.84 |
| Open | USD 59.05 |
| Day Range | USD 59.17 – 60.88 |
| 52-Week Range | USD 48.26 – 69.95 |
| Volume | 479,664 shares |
| Market Cap | $5.70B |
| Exchange | NYQ |
Technical Analysis (DLB)
Nexqual's technical model rates DLB "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 16, 2026 at 05:19 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 59.02 (neutral) |
| vs SMA50 | Above (USD 60.72) |
| MACD | -0.21 (negative) |
Analyst Ratings (DLB)
Wall Street analysts rate DLB "Buy" based on 4 analysts, with a mean price target of USD 79 (range USD 62–90), per Nexqual as of October 16, 2026 at 05:19 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 79 |
| High Target | USD 90 |
| Low Target | USD 62 |
| Buy / Hold / Sell | 3 / 1 / 0 |
Earnings (DLB)
| Next Earnings Date | 2026-11-17 |
|---|---|
| EPS Estimate | USD 1.2 |
| Revenue Estimate | $372.76M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.69 vs est 0.67 ▲ beat |
| 2026-03-31 | USD 1.37 vs est 1.34 ▲ beat |
| 2025-12-31 | USD 1.06 vs est 0.99 ▲ beat |
| 2025-09-30 | USD 0.99 vs est 0.71 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financials & Fundamentals (DLB)
| Total Revenue | $1.35B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -3.30% |
| Gross Margin | +87.61% |
| Operating Margin | +12.55% |
| Profit Margin | +16.70% |
| ROE | +8.76% |
| Debt / Equity | 0.02 |
| Current Ratio | 3.19 |
| Total Cash | $670.05M |
| Total Debt | $47.45M |
| Free Cash Flow (fiscal year ended Sep 2025, SEC 10-K) | $435.85M (32.3% of revenue) |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financial Health Score (DLB)
Nexqual rates Dolby Laboratories, Inc.'s overall financial health "Solid" across five dimensions, as of October 16, 2026 at 05:19 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 88%, operating 13% |
| Balance Sheet | Strong — $670M cash vs $47M debt, net cash position |
| Cash Flow | Strong — FCF $436M (FY ended Sep 2025, 10-K), 32% margin |
| Efficiency | Mixed — ROE 9%, ROA 5.2% |
Ownership (DLB)
| Insider Ownership | +1.87% |
|---|---|
| Institutional Ownership | +106.88% |
| Shares Outstanding | 59.42M |
| Float | 58.76M |
| Short % of Float | +13.43% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Leadership (DLB)
Dolby Laboratories, Inc. is led by Marc Whitten (age 54), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:19 UTC.
| President, CEO & Director | Marc Whitten (age 54) |
|---|---|
| Senior VP & CFO | Robert J. Park (age 55) |
| Senior Vice President of Entertainment | John D. Couling (age 50) |
| Senior Vice President of Advanced Technology Group | Shriram Revankar (age 63) |
| Vice President of Investor Relations | Peter L. Goldmacher |
Major Backers & Investors (DLB)
Notable institutional backers of Dolby Laboratories, Inc. include Morgan Stanley, First Trust Advisors LP, Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund, according to Nexqual as of October 16, 2026 at 05:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 7.74% |
| First Trust Advisors LP | 4.55% |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 3.73% |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 3.33% |
| Acadian Asset Management. LLC | 3.19% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 22.22% |
| BlackRock | 14.8% |
| BNY Mellon | 10.25% |
| State Street | 3.9% |
| Geode Capital | 3.1% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UNF | Unifirst Corporation | USD 264.83 | ▲ 2.62% |
| AMTM | Amentum Holdings, Inc. | USD 19.09 | ▲ 3.08% |
| AZZ | AZZ Inc. | USD 130.59 | ▼ 4.48% |
| FA | First Advantage Corporation | USD 20.08 | ▲ 4.31% |
| MMS | Maximus, Inc. | USD 60.24 | ▲ 3.72% |
| RTO | Rentokil Initial plc | USD 20.82 | ▲ 2.21% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:19 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt